Drug pricing watchdogs worry President Donald Trump’s plan to assess 100% tariffs on some imported brand name drugs could lighten patients pocketbooks. But that fate is far from certain, given caveats the Trump administration announced as part of a sweeping April 2 order on tariffs for imported brand name pharmaceuticals. Drugmakers that agree to move production to the United States will face…





















